Financial Summary (All financials)
In millions, except per share items | Dec-31-16 | Dec-31-15 | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
Revenues | 1.2 | 0.4 | 0.0 | 0.0 | 0.0 | 57.7 | 0.1 | 0.1 |
Revenue growth | 190.8% | 927.5% | 100.0% | | -100.0% | 57611.0% | 8.7% | -63.3% |
Cost of goods sold | 0.6 | 0.2 | 0.0 | 0.0 | 0.0 | 0.0 | 0.3 | 0.0 |
Gross profit | 0.6 | 0.2 | 0.0 | 0.0 | 0.0 | 57.7 | -0.2 | 0.1 |
Gross margin | 51.0% | 41.4% | 0.0% | 0.0% | | 99.9% | -222.0% | 83.7% |
Sales and marketing | 1.9 | 11.2 | 2.2 | | | | | |
Research and development | 29.0 | -18.7 | -17.2 | -11.2 | 23.9 | 51.5 | -7.4 | 0.4 |
General and administrative | 5.2 | 6.0 | 6.0 | 6.7 | 4.9 | 5.3 | 8.0 | 10.1 |
EBIT | -7.8 | -18.1 | -9.3 | -7.6 | -6.8 | -7.5 | -11.2 | -13.6 |
EBIT margin | -656.2% | -4402.9% | -23262.5% | -37970.0% | | -13.1% | -11215.0% | -14798.9% |
Pre-tax income | -10.0 | -41.0 | -27.4 | -20.9 | -4.9 | 15.1 | -56.9 | -16.8 |
Income taxes | 0.0 | -0.6 | -2.0 | 0.0 | -3.0 | 0.0 | 0.0 | 0.0 |
Tax rate | 0.0% | 1.4% | 7.4% | | 60.7% | 0.0% | 0.0% | 0.0% |
Net income | -10.0 | -40.4 | -25.4 | -20.9 | -1.9 | 15.1 | -56.9 | -16.8 |
Net margin | -840.3% | -9825.1% | -63450.0% | -104695.0% | | 26.1% | -56909.0% | -18283.7% |
|
Diluted EPS | ($0.17) | ($0.67) | ($0.42) | ($0.35) | ($0.03) | $0.25 | ($1.23) | ($0.49) |
Shares outstanding (diluted) | 60.7 | 60.7 | 60.7 | 60.7 | 60.7 | 59.3 | 46.2 | 34.7 |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|